Patent AT-E400301-T1: [Translated] ARTERIOVENOUS AND VENOUS TRANSPLANT TREATMENTS: METHODS AND COMPOSITIONS
Description
A method and compounds are provided for inhibiting the synthesis of extracellular matrix proteins. Compounds of the invention comprise oligonucleotides specific for nuclear proto-oncogenes. Preferably, oligonucleotides of the invention are selected from the group consisting of c-myc and c-myb and are locally administered. The invention finds use in the treatment of a variety of disorders, including sclerotic disorders and restenosis, associated with the inappropriate synthesis of extracellular matrix proteins, particularly collagen.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the complete Patent AT-E400301-T1: [Translated] ARTERIOVENOUS AND VENOUS TRANSPLANT TREATMENTS: METHODS AND COMPOSITIONS on the official website. |
https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400301-T1 |
Tags
- patent
- chemistry
- research
- innovation
- pubchem